Concurrent profound response of both Waldenström’s macroglobulinemia and myeloproliferative neoplasm to zanubrutinib
Hematology in Clinical Practice · 13.02.2026 · 17
DOI: 10.5603/hicp.108160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematology in Clinical Practice, online erschienen am 13.02.2026. Verfasst von Jarosław Grzyb und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Grzyb, J., Wojtaszewska, M., Szarawarska, M., Blajer-Olszewska, B., Moskwa, M., Rejus-Gajdek, A., Łączak, J., Kot, S., Chwiej-Grzyb, N., Kopacz, A., & Markiewicz, M. (2026). Concurrent profound response of both Waldenström’s macroglobulinemia and myeloproliferative neoplasm to zanubrutinib. Hematology in Clinical Practice, 17(0). https://doi.org/10.5603/hicp.108160
Vancouver
Grzyb J, Wojtaszewska M, Szarawarska M, Blajer-Olszewska B, Moskwa M, Rejus-Gajdek A, et al. Concurrent profound response of both Waldenström’s macroglobulinemia and myeloproliferative neoplasm to zanubrutinib. Hematology in Clinical Practice. 2026;17(0). doi:10.5603/hicp.108160
BibTeX
@article{Grzyb2026,
author = {Grzyb, Jarosław and Wojtaszewska, Marzena and Szarawarska, Marta and Blajer-Olszewska, Beata and Moskwa, Monika and Rejus-Gajdek, Aleksandra and Łączak, Jakub and Kot, Sylwia and Chwiej-Grzyb, Natalia and Kopacz, Agnieszka and Markiewicz, Mirosław},
title = {Concurrent profound response of both Waldenström’s macroglobulinemia and myeloproliferative neoplasm to zanubrutinib},
journal = {Hematology in Clinical Practice},
year = {2026},
volume = {17},
number = {0},
doi = {10.5603/hicp.108160}
}
EUVIMED